feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Annexin Pharmaceuticals: Progress in phase I study
Research Note
2021-03-18
14:41
Redeye gives a short comment on the positive progress in Annexin's phase I study.
FT
AH
Fredrik Thor
Anders Hedlund
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans